April 8 and IS still has NO sales numbers

Quote

Anonymous

Guest
NO Quotas

NO Incentive sheet for January. Fucking January! January ended 67 days ago and still NO numbers.

Something is fishy. Operations is doctoring the numbers.

April 8 and NO quotas, NO sales numbers and yet we have a contract sales force to sell Tygacil.

Home Office: Go fuck yourself.
 




Anonymous said:
NO Quotas

NO Incentive sheet for January. Fucking January! January ended 67 days ago and still NO numbers.

Something is fishy. Operations is doctoring the numbers.

April 8 and NO quotas, NO sales numbers and yet we have a contract sales force to sell Tygacil.

Home Office: Go fuck yourself.
Click to expand...

Relax. Primary Care is in the same boat. New vendor. No one is doctoring the numbers. Relax. Just work until June- You will be gone then! Mark my words today!
 




Anonymous said:
NO Quotas

NO Incentive sheet for January. Fucking January! January ended 67 days ago and still NO numbers.

Something is fishy. Operations is doctoring the numbers.

April 8 and NO quotas, NO sales numbers and yet we have a contract sales force to sell Tygacil.

Home Office: Go fuck yourself.
Click to expand...

Settle down dude you care too much!! Just take it for what it is and enjoy the ride!!
 












Anonymous said:
NO Quotas

NO Incentive sheet for January. Fucking January! January ended 67 days ago and still NO numbers.

Something is fishy. Operations is doctoring the numbers.

April 8 and NO quotas, NO sales numbers and yet we have a contract sales force to sell Tygacil.

Home Office: Go fuck yourself.
Click to expand...

Dude, take a xanax, nobody has numbers. Enjoy it while it lasts.
 




Cutting corners on the only vendor that is important - sales numbers yet IS has the extra cash to run a 12 month pilot on Tygacil using "on the street" antibiotic reps? Do you understand that it's not detail sensitivity that hurt Tygacil, it's the consistent mortality blows followed by absolutely nothing new from a promotional standpoint.
 












Anyone find it unusual why they would add 10-20 contract reps at $1-3 million and cut IMS data to save $500,000 a year?

Also, Tyga not taking off because no new data, citizen petition to withdraw from market still pending FDA ruling and a PI that states IN BOLD: "All-Cause Mortality
An increase in all-cause mortality has been observed across Phase 3 and 4 clinical trials in TYGACIL-treated patients versus comparator-treated patients. This increase in all-cause mortality should be considered when selecting among treatment options."

Know Your Customer: Do No Harm

Do you really think I want to spend the next 10 years giving depositions to class-actions?
 




Anonymous said:
Anyone find it unusual why they would add 10-20 contract reps at $1-3 million and cut IMS data to save $500,000 a year?

Also, Tyga not taking off because no new data, citizen petition to withdraw from market still pending FDA ruling and a PI that states IN BOLD: "All-Cause Mortality
An increase in all-cause mortality has been observed across Phase 3 and 4 clinical trials in TYGACIL-treated patients versus comparator-treated patients. This increase in all-cause mortality should be considered when selecting among treatment options."

Know Your Customer: Do No Harm

Do you really think I want to spend the next 10 years giving depositions to class-actions?
Click to expand...

Really good insights here. Wish someone would have thought of these things a year or two ago. Looks like you are smart enough to leave. BYE!
 




















Top Bottom
Back
Quote